IATA: COVID-19 testing, contactless tech, mobile apps and offsite processing critical to restoring air travel
CVS Health Gets A Buy Rating From Piper Sandler
Politics is wrecking America’s pandemic response
Tucker Slams Facebook Censorship Of Chinese Virologist: "It's Turning Us Into The Soviet Union"
Eli Lilly Strikes Deal With Amgen To Manufacture Covid-19 Antibody Therapies
Moderna Stock Rises 3% On Vertex Deal
BioNTech Buys German Site From Novartis To Boost Covid-19 Vaccine Supply
Futures Slide After Fed "Not-Dovish-Enough", Tech Tumbles On Reflation Rotation Fears
Covid-19 roundup: Trump questions Redfield after hearing remarks; Oxford suggests side effect not caused by vaccine
Sorrento Pops 28% On FDA Nod To Kick Off Covid-19 Antibody Trial
Illumina Eyes Grail Acquisition For Over $8B – Report
SmartNews’ U.S. app unveils new features for the elections, COVID-19 and local weather
AstraZeneca’s trial illnesses may not be due to Covid-19 shot, Oxford University says
China’s Sinovac to test coronavirus vaccine candidate in teenagers, children
Trump Agrees With Powell: "Much Higher" Fiscal Stimulus Is Needed... And Why That Could Crash Stocks
Tyranny Down Under: From Blue Shirts To Brown
Dalio Sheds Light On Chinese Thinking On Trade Deal
"The Virus Isn't Going Away... Campuses Need To Reopen", Northeastern Uni President Warns
Novavax Ramps Up Manufacturing for COVID-19 Vaccine; Analyst Cheers
Broad U.S. rollout of coronavirus vaccine could happen mid-2021: CDC
Vaxart Can Still Be a Major Force in the COVID-19 Vaccine Landscape, Says Analyst
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
AstraZeneca’s trial illnesses may not be due to Covid-19 shot – Oxford University
Concerns Mount – FDA May Approve Deadly Vaccine
Bill Gates embroiled in controversy over coronavirus vaccine safety
NIH Raises Concerns About Potential Safety Issues Associated with AstraZeneca Vaccine
Eli Lilly’s Antibody Therapy Against Covid-19 Reduced Hospitalization Rates
iBio’s FastPharming Platform Produces Decoy Therapeutic to Bind to SARS-CoV-2
Former FDA Executive on COVID-19 and Convalescent Plasma
Step Aside FAAMGs: Goldman Presents The "Future Five" Stocks That Will Define The Decade